Science 29 April 1994: Vol. 264. no. 5159, pp. 707 - 710 DOI: 10.1126/science.8171323

Prev | Table of Contents | Next

Articles

Targeting Lymphotoxin {beta} Receptor with Tumor-Specific T Lymphocytes for Tumor Regression.

D. Yang, N. ud Din, D. D. Browning, S. I. Abrams, and K. Liu (2007)
Clin. Cancer Res. 13, 5202-5210
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin {beta} Receptor (Lt{beta}R): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using Lt{beta}R-Ig Protein.

S. R. Plant, H. A. Iocca, Y. Wang, J. C. Thrash, B. P. O'Connor, H. A. Arnett, Y.-X. Fu, M. J. Carson, and J. P.-Y. Ting (2007)
J. Neurosci. 27, 7429-7437
 |  Abstract »  |  Full Text »  |  PDF »

A unique lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of V{alpha}14 invariant natural killer T cells.

A. S. Franki, K. Van Beneden, P. Dewint, K. J. L. Hammond, S. Lambrecht, G. Leclercq, M. Kronenberg, D. Deforce, and D. Elewaut (2006)
PNAS 103, 9160-9165
 |  Abstract »  |  Full Text »  |  PDF »

LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM.

S.-K. Heo, S.-A Ju, S.-C. Lee, S.-M. Park, S.-Y. Choe, B. Kwon, B. S. Kwon, and B.-S. Kim (2006)
J. Leukoc. Biol. 79, 330-338
 |  Abstract »  |  Full Text »  |  PDF »

Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-{beta} receptor expression.

F. Stevenaert, K. Van Beneden, V. De Colvenaer, A. S. Franki, V. Debacker, T. Boterberg, D. Deforce, K. Pfeffer, J. Plum, D. Elewaut, et al. (2005)
Blood 106, 956-962
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Vaccine Based on Cell Surface Expression of DcR3/TR6.

G. Shi, J. Mao, G. Yu, J. Zhang, and J. Wu (2005)
J. Immunol. 174, 4727-4735
 |  Abstract »  |  Full Text »  |  PDF »

Distinct Roles for Lymphotoxin-{alpha} and Tumor Necrosis Factor in the Control of Leishmania donovani Infection.

C. R. Engwerda, M. Ato, S. Stager, C. E. Alexander, A. C. Stanley, and P. M. Kaye (2004)
Am. J. Pathol. 165, 2123-2133
 |  Abstract »  |  Full Text »  |  PDF »

Role of Gut-Associated Lymphoreticular Tissues in Antigen-Specific Intestinal IgA Immunity.

M. Yamamoto, M.-N. Kweon, P. D. Rennert, T. Hiroi, K. Fujihashi, J. R. McGhee, and H. Kiyono (2004)
J. Immunol. 173, 762-769
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin-{beta} Receptor Activation by Activated T Cells Induces Cytokine Release from Mouse Bone Marrow-Derived Mast Cells.

P. Stopfer, D. N. Mannel, and T. Hehlgans (2004)
J. Immunol. 172, 7459-7465
 |  Abstract »  |  Full Text »  |  PDF »

TNF and Phorbol Esters Induce Lymphotoxin-{beta} Expression through Distinct Pathways Involving Ets and NF-{kappa}B Family Members.

D. C. Voon, L. S. Subrata, M. Karimi, D. Ulgiati, and L. J. Abraham (2004)
J. Immunol. 172, 4332-4341
 |  Abstract »  |  Full Text »  |  PDF »

Structurally Distinct Recognition Motifs in Lymphotoxin-{beta} Receptor and CD40 for Tumor Necrosis Factor Receptor-associated Factor (TRAF)-mediated Signaling.

C. Li, P. S. Norris, C.-Z. Ni, M. L. Havert, E. M. Chiong, B. R. Tran, E. Cabezas, J. C. Reed, A. C. Satterthwait, C. F. Ware, et al. (2003)
J. Biol. Chem. 278, 50523-50529
 |  Abstract »  |  Full Text »  |  PDF »

Both Lymphotoxin-{alpha} and TNF Are Crucial for Control of Toxoplasma gondii in the Central Nervous System.

D. Schluter, L.-Y. Kwok, S. Lutjen, S. Soltek, S. Hoffmann, H. Korner, and M. Deckert (2003)
J. Immunol. 170, 6172-6182
 |  Abstract »  |  Full Text »  |  PDF »

Immune system and peripheral nerves in propagation of prions to CNS.

A. Aguzzi, F. L Heppner, M. Heikenwalder, M. Prinz, K. Mertz, H. Seeger, and M. Glatzel (2003)
Br. Med. Bull. 66, 141-159
 |  Abstract »  |  Full Text »  |  PDF »

Ectopic LT{alpha}{beta} Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase.

D. L. Drayton, X. Ying, J. Lee, W. Lesslauer, and N. H. Ruddle (2003)
J. Exp. Med. 197, 1153-1163
 |  Abstract »  |  Full Text »  |  PDF »

The Role of Apoptosis Signal-regulating Kinase 1 in Lymphotoxin-beta Receptor-mediated Cell Death.

M.-C. Chen, M.-J. Hwang, Y.-C. Chou, W.-H. Chen, G. Cheng, H. Nakano, T.-Y. Luh, S.-C. Mai, and S.-L. Hsieh (2003)
J. Biol. Chem. 278, 16073-16081
 |  Abstract »  |  Full Text »  |  PDF »

Redundancy in Tumor Necrosis Factor (TNF) and Lymphotoxin (LT) Signaling In Vivo: Mice with Inactivation of the Entire TNF/LT Locus versus Single-Knockout Mice.

D. V. Kuprash, M. B. Alimzhanov, A. V. Tumanov, S. I. Grivennikov, A. N. Shakhov, L. N. Drutskaya, M. W. Marino, R. L. Turetskaya, A. O. Anderson, K. Rajewsky, et al. (2002)
Mol. Cell. Biol. 22, 8626-8634
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin-{alpha}-Deficient Mice Make Delayed, But Effective, T and B Cell Responses to Influenza.

F. E. Lund, S. Partida-Sanchez, B. O. Lee, K. L. Kusser, L. Hartson, R. J. Hogan, D. L. Woodland, and T. D. Randall (2002)
J. Immunol. 169, 5236-5243
 |  Abstract »  |  Full Text »  |  PDF »

BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases.

V. Roschke, S. Sosnovtseva, C. D. Ward, J. S. Hong, R. Smith, V. Albert, W. Stohl, K. P. Baker, S. Ullrich, B. Nardelli, et al. (2002)
J. Immunol. 169, 4314-4321
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin-{beta} Receptor Immune Interaction Promotes Tumor Growth by Inducing Angiogenesis.

T. Hehlgans, B. Stoelcker, P. Stopfer, P. Muller, G. Cernaianu, M. Guba, M. Steinbauer, S. A. Nedospasov, K. Pfeffer, and D. N. Mannel (2002)
Cancer Res. 62, 4034-4040
 |  Abstract »  |  Full Text »  |  PDF »

Targeted Disruption of LIGHT Causes Defects in Costimulatory T Cell Activation and Reveals Cooperation with Lymphotoxin {beta} in Mesenteric Lymph Node Genesis.

S. Scheu, J. Alferink, T. Potzel, W. Barchet, U. Kalinke, and K. Pfeffer (2002)
J. Exp. Med. 195, 1613-1624
 |  Abstract »  |  Full Text »  |  PDF »

B Cells Control the Migration of a Subset of Dendritic Cells into B Cell Follicles Via CXC Chemokine Ligand 13 in a Lymphotoxin-Dependent Fashion.

P. Yu, Y. Wang, R. K. Chin, L. Martinez-Pomares, S. Gordon, M. H. Kosco-Vibois, J. Cyster, and Y.-X. Fu (2002)
J. Immunol. 168, 5117-5123
 |  Abstract »  |  Full Text »  |  PDF »

Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells.

A. J. da Silva, M. Brickelmaier, G. R. Majeau, Z. Li, L. Su, Y.-M. Hsu, and P. S. Hochman (2002)
J. Immunol. 168, 4462-4471
 |  Abstract »  |  Full Text »  |  PDF »

Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines.

D. S. Weih, Z. B. Yilmaz, and F. Weih (2001)
J. Immunol. 167, 1909-1919
 |  Abstract »  |  Full Text »  |  PDF »

A Monoclonal Antibody That Induces Neuronal Apoptosis Binds a Metastasis Marker.

L.-t. Zhong, A. Manzi, E. Skowronski, L. Notterpek, A. L. Fluharty, K. F. Faull, I. Masada, S. Rabizadeh, M. Varsanyi-Nagy, Y. Ruan, et al. (2001)
Cancer Res. 61, 5741-5748
 |  Abstract »  |  Full Text »  |  PDF »

Secreted Lymphotoxin-{{alpha}} Is Essential for the Control of an Intracellular Bacterial Infection.

D. R. Roach, H. Briscoe, B. Saunders, M. P. France, S. Riminton, and W. J. Britton (2001)
J. Exp. Med. 193, 239-246
 |  Abstract »  |  Full Text »  |  PDF »

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.

L. Probert, H.-P. Eugster, K. Akassoglou, J. Bauer, K. Frei, H. Lassmann, and A. Fontana (2000)
Brain 123, 2005-2019
 |  Abstract »  |  Full Text »  |  PDF »

Membrane Lymphotoxin Is Required for the Development of Different Subpopulations of NK T Cells.

D. Elewaut, L. Brossay, S. M. Santee, O. V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C. F. Ware, H. Cheroutre, and M. Kronenberg (2000)
J. Immunol. 165, 671-679
 |  Abstract »  |  Full Text »  |  PDF »

BAFF Binds to the Tumor Necrosis Factor Receptor-like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population.

J. S. Thompson, P. Schneider, S. L. Kalled, L. Wang, E. A. Lefevre, T. G. Cachero, F. MacKay, S. A. Bixler, M. Zafari, Z.-Y. Liu, et al. (2000)
J. Exp. Med. 192, 129-136
 |  Abstract »  |  Full Text »  |  PDF »

The Lymphotoxin-beta Receptor Is Necessary and Sufficient for LIGHT-mediated Apoptosis of Tumor Cells.

I. A. Rooney, K. D. Butrovich, A. A. Glass, S. Borboroglu, C. A. Benedict, J. C. Whitbeck, G. H. Cohen, R. J. Eisenberg, and C. F. Ware (2000)
J. Biol. Chem. 275, 14307-14315
 |  Abstract »  |  Full Text »  |  PDF »

Alymphoplasia (aly)-type Nuclear Factor {kappa}B-inducing Kinase (NIK) Causes Defects in Secondary Lymphoid Tissue Chemokine Receptor Signaling and Homing of Peritoneal Cells to the Gut-associated Lymphatic Tissue System.

S. Fagarasan, R. Shinkura, T. Kamata, F. Nogaki, K. Ikuta, K. Tashiro, and T. Honjo (2000)
J. Exp. Med. 191, 1477-1486
 |  Abstract »  |  Full Text »  |  PDF »

Discrete Signaling Regions in the Lymphotoxin-beta Receptor for Tumor Necrosis Factor Receptor-associated Factor Binding, Subcellular Localization, and Activation of Cell Death and NF-kappa B Pathways.

W. R. Force, A. A. Glass, C. A. Benedict, T. C. Cheung, J. Lama, and C. F. Ware (2000)
J. Biol. Chem. 275, 11121-11129
 |  Abstract »  |  Full Text »  |  PDF »

Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity.

A. D. Weinberg, M.-M. Rivera, R. Prell, A. Morris, T. Ramstad, J. T. Vetto, W. J. Urba, G. Alvord, C. Bunce, and J. Shields (2000)
J. Immunol. 164, 2160-2169
 |  Abstract »  |  Full Text »  |  PDF »

The Requirement of Membrane Lymphotoxin for the Presence of Dendritic Cells in Lymphoid Tissues.

Q. Wu, Y. Wang, J. Wang, E. O. Hedgeman, J. L. Browning, and Y.-X. Fu (1999)
J. Exp. Med. 190, 629-638
 |  Abstract »  |  Full Text »  |  PDF »

Mice with a Targeted Mutation in Lymphotoxin-{alpha} Exhibit Enhanced Tumor Growth and Metastasis: Impaired NK Cell Development and Recruitment.

D. Ito, T. C. Back, A. N. Shakhov, R. H. Wiltrout, and S. A. Nedospasov (1999)
J. Immunol. 163, 2809-2815
 |  Abstract »  |  Full Text »  |  PDF »

Multiple Deficiencies Underlie NK Cell Inactivity in Lymphotoxin-{alpha} Gene-Targeted Mice.

M. J. Smyth, R. W. Johnstone, E. Cretney, N. M. Haynes, J. D. Sedgwick, H. Korner, L. D. Poulton, and A. G. Baxter (1999)
J. Immunol. 163, 1350-1353
 |  Abstract »  |  Full Text »  |  PDF »

Involvement of Distinct Cellular Compartments in the Abnormal Lymphoid Organogenesis in Lymphotoxin-{alpha}-Deficient Mice and Alymphoplasia (aly) Mice Defined by the Chimeric Analysis.

M. Matsumoto, K. Iwamasa, P. D. Rennert, T. Yamada, R. Suzuki, A. Matsushima, M. Okabe, S. Fujita, and M. Yokoyama (1999)
J. Immunol. 163, 1584-1591
 |  Abstract »  |  Full Text »  |  PDF »

Requirement for membrane lymphotoxin in natural killer cell development.

K. Iizuka, D. D. Chaplin, Y. Wang, Q. Wu, L. E. Pegg, W. M. Yokoyama, and Y.-X. Fu (1999)
PNAS 96, 6336-6340
 |  Abstract »  |  Full Text »  |  PDF »

Signaling Through the Lymphotoxin-{beta} Receptor Stimulates HIV-1 Replication Alone and in Cooperation with Soluble or Membrane-Bound TNF-{alpha}.

W. L. Marshall, B. M. N. Brinkman, C. M. Ambrose, P. A. Pesavento, A. M. Uglialoro, E. Teng, R. W. Finberg, J. L. Browning, and A. E. Goldfeld (1999)
J. Immunol. 162, 6016-6023
 |  Abstract »  |  Full Text »  |  PDF »

The Cytoplasmic Domain of the Lymphotoxin-{beta} Receptor Mediates Cell Death in HeLa Cells.

M.-Y. Wu, P.-Y. Wang, S.-H. Han, and S.-L. Hsieh (1999)
J. Biol. Chem. 274, 11868-11873
 |  Abstract »  |  Full Text »  |  PDF »

Hepatitis C Virus Core Protein Enhances NF-kappa B Signal Pathway Triggering by Lymphotoxin-beta Receptor Ligand and Tumor Necrosis Factor Alpha.

L.-R. You, C.-M. Chen, and Y.-H. W. Lee (1999)
J. Virol. 73, 1672-1681
 |  Abstract »  |  Full Text »

Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin beta  Receptor by Radioresistant Stromal Cells and of Lymphotoxin beta  and Tumor Necrosis Factor by B Cells.

R. Endres, M. B. Alimzhanov, T. Plitz, A. Futterer, M. H. Kosco-Vilbois, S. A. Nedospasov, K. Rajewsky, and K. Pfeffer (1999)
J. Exp. Med. 189, 159-168
 |  Abstract »  |  Full Text »  |  PDF »

Autocrine Tumor Necrosis Factor (TNF) and Lymphotoxin (LT) alpha  Differentially Modulate Cellular Sensitivity to TNF/LT-alpha Cytotoxicity in L929 Cells.

E. Decoster, S. Cornelis, B. Vanhaesebroeck, and W. Fiers (1998)
J. Cell Biol. 143, 2057-2065
 |  Abstract »  |  Full Text »  |  PDF »

Efficient, Repeated Adenovirus-Mediated Gene Transfer in Mice Lacking both Tumor Necrosis Factor Alpha and Lymphotoxin alpha.

K. Benihoud, I. Saggio, P. Opolon, B. Salone, F. Amiot, E. Connault, C. Chianale, F. Dautry, P. Yeh, and M. Perricaudet (1998)
J. Virol. 72, 9514-9525
 |  Abstract »  |  Full Text »  |  PDF »

Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell Growth.

J. A. Harrop, P. C. McDonnell, M. Brigham-Burke, S. D. Lyn, J. Minton, K. B. Tan, K. Dede, J. Spampanato, C. Silverman, P. Hensley, et al. (1998)
J. Biol. Chem. 273, 27548-27556
 |  Abstract »  |  Full Text »  |  PDF »

Transfer of Primitive Stem/Progenitor Bone Marrow Cells from LT{alpha}-/- Donors to Wild-Type Hosts: Implications for the Generation of Architectural Events in Lymphoid B Cell Domains.

R. E. Mebius, S. van Tuijl, I. L. Weissman, and T. D. Randall (1998)
J. Immunol. 161, 3836-3843
 |  Abstract »  |  Full Text »  |  PDF »

Complementation of Lymphotoxin alpha  Knockout Mice with Tumor Necrosis Factor-expressing Transgenes Rectifies Defective Splenic Structure and Function.

L. Alexopoulou, M. Pasparakis, and G. Kollias (1998)
J. Exp. Med. 188, 745-754
 |  Abstract »  |  Full Text »  |  PDF »

A Role for Tumor Necrosis Factor Receptor Type 1 in Gut-associated Lymphoid Tissue Development: Genetic Evidence of Synergism with Lymphotoxin beta  .

P. A. Koni and R. A. Flavell (1998)
J. Exp. Med. 187, 1977-1983
 |  Abstract »  |  Full Text »  |  PDF »

Challenging Cytokine Redundancy: Inflammatory Cell Movement and Clinical Course of Experimental Autoimmune Encephalomyelitis Are Normal in Lymphotoxin-deficient, but Not Tumor Necrosis Factor-deficient, Mice.

D. Sean Riminton, H. Korner, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick (1998)
J. Exp. Med. 187, 1517-1528
 |  Abstract »  |  Full Text »  |  PDF »

The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles.

M. Gonzalez, F. Mackay, J. L. Browning, M. H. Kosco-Vilbois, and R. J. Noelle (1998)
J. Exp. Med. 187, 997-1007
 |  Abstract »  |  Full Text »  |  PDF »

B Lymphocytes Induce the Formation of Follicular Dendritic Cell Clusters in a Lymphotoxin alpha -dependent Fashion.

Y.-X. Fu, G. Huang, Y. Wang, and D. D. Chaplin (1998)
J. Exp. Med. 187, 1009-1018
 |  Abstract »  |  Full Text »  |  PDF »

Crucial Role of Tumor Necrosis Factor Receptor 1 Expression on Nonhematopoietic Cells for B Cell Localization within the Splenic White Pulp.

M. Tkachuk, S. Bolliger, B. Ryffel, G. Pluschke, T. A. Banks, S. Herren, R. H. Gisler, and M. H. Kosco-Vilbois (1998)
J. Exp. Med. 187, 469-477
 |  Abstract »  |  Full Text »  |  PDF »

TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation.

J. J. Peschon, D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler (1998)
J. Immunol. 160, 943-952
 |  Abstract »  |  Full Text »  |  PDF »

Differential Activities of Secreted Lymphotoxin-{alpha}3 and Membrane Lymphotoxin-{alpha}1{beta}2 in Lymphotoxin-Induced Inflammation: Critical Role of TNF Receptor 1 Signaling.

R. Sacca, C. A. Cuff, W. Lesslauer, and N. H. Ruddle (1998)
J. Immunol. 160, 485-491
 |  Abstract »  |  Full Text »  |  PDF »

Distinct Roles of Lymphotoxin alpha  and the Type I Tumor Necrosis Factor (TNF) Receptor in the Establishment of Follicular Dendritic Cells from Non-Bone Marrow-derived Cells.

M. Matsumoto, Y.-X. Fu, H. Molina, G. Huang, J. Kim, D. A. Thomas, M. H. Nahm, and D. D. Chaplin (1997)
J. Exp. Med. 186, 1997-2004
 |  Abstract »  |  Full Text »  |  PDF »

Dominant Negative Mutants of TRAF3 Reveal an Important Role for the Coiled Coil Domains in Cell Death Signaling by the Lymphotoxin-beta Receptor.

W. R. Force, T. C. Cheung, and C. F. Ware (1997)
J. Biol. Chem. 272, 30835-30840
 |  Abstract »  |  Full Text »  |  PDF »

A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis.

W. E. Suen, C. M. Bergman, P. Hjelmstrom, and N. H. Ruddle (1997)
J. Exp. Med. 186, 1233-1240
 |  Abstract »  |  Full Text »  |  PDF »

Abnormal development of secondary lymphoid tissues in lymphotoxin beta -deficient mice.

M. B. Alimzhanov, D. V. Kuprash, M. H. Kosco-Vilbois, A. Luz, R. L. Turetskaya, A. Tarakhovsky, K. Rajewsky, S. A. Nedospasov, and K. Pfeffer (1997)
PNAS 94, 9302-9307
 |  Abstract »  |  Full Text »  |  PDF »

The Lymphotoxin-alpha (LTalpha ) Subunit Is Essential for the Assembly, but Not for the Receptor Specificity, of the Membrane-anchored LTalpha 1beta 2 Heterotrimeric Ligand.

L. Williams-Abbott, B. N. Walter, T. C. Cheung, C. R. Goh, A. G. Porter, and C. F. Ware (1997)
J. Biol. Chem. 272, 19451-19456
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of tumor necrosis factor-deficient mice.

M. W. Marino, A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. (1997)
PNAS 94, 8093-8098
 |  Abstract »  |  Full Text »  |  PDF »

Serine/Threonine Kinase Activity Associated with the Cytoplasmic Domain of the Lymphotoxin-beta Receptor in HepG2 Cells.

M.-Y. Wu, T.-L. Hsu, W.-W. Lin, R. D. Campbell, and S.-L. Hsieh (1997)
J. Biol. Chem. 272, 17154-17159
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin-alpha (LTalpha ) Supports Development of Splenic Follicular Structure That Is Required for IgG Responses.

Y.-X. Fu, H. Molina, M. Matsumoto, G. Huang, J. Min, and D. D. Chaplin (1997)
J. Exp. Med. 185, 2111-2120
 |  Abstract »  |  Full Text »  |  PDF »

Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.

M. Pasparakis, L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias (1997)
PNAS 94, 6319-6323
 |  Abstract »  |  Full Text »  |  PDF »

Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node.

Y.-X. Fu, G. Huang, M. Matsumoto, H. Molina, and D. D. Chaplin (1997)
PNAS 94, 5739-5743
 |  Abstract »  |  Full Text »  |  PDF »

Human lymphotoxin mutein lacks hypotensive activity but has higher in vivo antitumor activity than lymphotoxin or tumor necrosis factor.

M. Taniyama, T. Morita, Y. Yamagishi, A. Kato, C. Bando, N. Okawa, and A. Kaji (1997)
PNAS 94, 3324-3329
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin-beta receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappa B.

T. L. VanArsdale, S. L. VanArsdale, W. R. Force, B. N. Walter, G. Mosialos, E. Kieff, J. C. Reed, and C. F. Ware (1997)
PNAS 94, 2460-2465
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of T-Cell Clones Derived From Peripheral Blood Lymphocytes of a Patient With Transfusion-Associated Graft-Versus-Host Disease: Fas-Mediated Killing by CD4+ and CD8+ Cytotoxic T-Cell Clones and Tumor Necrosis Factor beta  Production by CD4+ T-Cell Clones.

M. Nishimura, S. Uchida, S. Mitsunaga, Y. Yahagi, K. Nakajima, K. Tadokoro, and T. Juji (1997)
Blood 89, 1440-1445
 |  Abstract »  |  Full Text »  |  PDF »

Immunological defects in mice with a targeted disruption in Bcl-3..

E M Schwarz, P Krimpenfort, A Berns, and I M Verma (1997)
Genes & Dev. 11, 187-197
 |  Abstract »  |  PDF »

Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.

R. Ettinger, J. L. Browning, S. A. Michie, W. van Ewijk, and H. O. McDevitt (1996)
PNAS 93, 13102-13107
 |  Abstract »  |  Full Text »  |  PDF »

Lymphotoxin beta Receptor Triggering Induces Activation of the Nuclear Factor kappa B Transcription Factor in Some Cell Types.

F. Mackay, G. R. Majeau, P. S. Hochman, and J. L. Browning (1996)
J. Biol. Chem. 271, 24934-24938
 |  Abstract »  |  Full Text »  |  PDF »

The Tumor Necrosis Factor Ligand and Receptor Families.

F. Bazzoni and B. Beutler (1996)
N. Engl. J. Med. 334, 1717-1725
 |  Full Text »  |  PDF »

TRAF5, an Activator of NF-kappa B and Putative Signal Transducer for the Lymphotoxin-beta Receptor.

H. Nakano, H. Oshima, W. Chung, L. Williams-Abbott, C. F. Ware, H. Yagita, and K. Okumura (1996)
J. Biol. Chem. 271, 14661-14664
 |  Abstract »  |  Full Text »  |  PDF »

REVIEW {blacksquare} : Keeping Neurons Alive: The Molecular Control of Apoptosis (Part I.

D. E. Bredesen (1996)
Neuroscientist 2, 181-190
 |  Abstract »  |  PDF »

Distinct Roles of the Two Tumor Necrosis Factor (TNF) Receptors in Modulating TNF and Lymphotoxin alpha Effects.

A. E. Medvedev, T. Espevik, G. Ranges, and A. Sundan (1996)
J. Biol. Chem. 271, 9778-9784
 |  Abstract »  |  Full Text »  |  PDF »

Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins alpha and beta.

J. L. Browning, K. Miatkowski, D. A. Griffiths, P. R. Bourdon, C. Hession, C. M. Ambrose, and W. Meier (1996)
J. Biol. Chem. 271, 8618-8626
 |  Abstract »  |  Full Text »  |  PDF »

Unraveling function in the TNF ligand and receptor families.

B Beutler and C van Huffel (1994)
Science 264, 667-668
 |  PDF »

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.

P De Togni, J Goellner, N. Ruddle, P. Streeter, A Fick, S Mariathasan, S. Smith, R Carlson, L. Shornick, J Strauss-Schoenberger, et al. (1994)
Science 264, 703-707
 |  Abstract »  |  PDF »

Overexpression of Bcl-2 Enhances LIGHT- and Interferon-gamma -mediated Apoptosis in Hep3BT2 Cells.

M.-C. Chen, T.-L. Hsu, T.-Y. Luh, and S.-L. Hsieh (2000)
J. Biol. Chem. 275, 38794-38801
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products